Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification

Hector Martín Merinero, Yuzhou Zhang, Emilia Arjona, Guillermo del Angel, Renee Goodfellow, Elena Gomez-Rubio, Rui-Ru Ji, Malkoa Michelena, Richard J. H. Smith, Santiago Rodríguez de Córdoba

Blood (2021) 138 (22): 2185–2201.

https://doi.org/10.1182/blood.2021012037

Published: 2021

Includes: Supplemental data

Journal Articles

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

Elizabeth C. Schramm, Lubka T. Roumenina, Tania Rybkine, Sophie Chauvet, Paula Vieira-Martins, Christophe Hue, Tara Maga, Elisabetta Valoti, Valerie Wilson, Sakari Jokiranta, Richard J. H. Smith, Marina Noris, Tim Goodship, John P. Atkinson, Veronique Fremeaux-Bacchi

Blood (2015) 125 (15): 2359–2369.

https://doi.org/10.1182/blood-2014-10-609073

Published: 2015

Includes: Supplemental data

Journal Articles

The Alternate Complement Pathway in Thrombotic Thrombocytopenic Purpura

John C. Chapin, MD, Katrina Piskorski, Stephen J Eyler, MD, Richard J. H. Smith, MD, Jeffrey Laurence, MD

Blood (2012) 120 (21): 3342.

https://doi.org/10.1182/blood.V120.21.3342.3342

Published: 2012

Journal Articles

A Novel Hybrid CFH/CFHR1–3 Gene in Atypical Hemolytic Uremic Syndrome

Mehmet F. Hepgur, MD, Preeti Chaudhary, MD, Sarmen Sarkissian, MD, Richard J. H. Smith, MD, Howard Liebman, MD, Ilene C Weitz, MD

Blood (2012) 120 (21): 4644.

https://doi.org/10.1182/blood.V120.21.4644.4644

Published: 2012

Journal Articles

Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Patients with or without Identified Genetic Complement Mutations or Complement Factor H Auto-Antibodies.

Samhar I. Al-Akash, Timothy H. J. Goodship, MD, Richard J. H. Smith, MD, Christophe M. Legendre, MD, Christoph Licht, MD, Petra Muus, MD, PhD, Camille L. Bedrosian, MD, Veronique Frémeaux-Bacchi, PhD, Chantal Loirat, MD

Blood (2012) 120 (21): 2085.

https://doi.org/10.1182/blood.V120.21.2085.2085

Published: 2012

Journal Articles

ADAMTS13 Variants in Atypical Hemolytic Uremic Syndrome

Shuju Feng, PhD, Stephen J. Eyler, MD, Yuzhou Zhang, PhD, Tara K. Maga, MD, Michael H. Kroll, MD, Richard J. H. Smith, MD, Vahid Afshar-Kharghan, MD

Blood (2012) 120 (21): 490.

https://doi.org/10.1182/blood.V120.21.490.490

Published: 2012

NARROW

Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

The Alternate Complement Pathway in Thrombotic Thrombocytopenic Purpura

A Novel Hybrid CFH/CFHR1–3 Gene in Atypical Hemolytic Uremic Syndrome

Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Patients with or without Identified Genetic Complement Mutations or Complement Factor H Auto-Antibodies.

ADAMTS13 Variants in Atypical Hemolytic Uremic Syndrome

Email alerts

ASH Publications

American Society of Hematology

Functional characterization of 105 factor H variants associated with aHUS: lessons for variant classification

Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome

The Alternate Complement Pathway in Thrombotic Thrombocytopenic Purpura

A Novel Hybrid CFH/CFHR1–3 Gene in Atypical Hemolytic Uremic Syndrome

Eculizumab Is an Effective Treatment for Atypical Hemolytic Uremic Syndrome in Patients with or without Identified Genetic Complement Mutations or Complement Factor H Auto-Antibodies.

ADAMTS13 Variants in Atypical Hemolytic Uremic Syndrome

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only